BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 16445845)

  • 21. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
    Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prophylaxis of fungal infection in patients with hematologic neoplasms and severe neutropenia after high-dose chemotherapy].
    Minenko SV; Zhukov NV; Chimishkian KL; Sokolova EN; Ptushkin VV
    Antibiot Khimioter; 2004; 49(8-9):52-6. PubMed ID: 15727147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical features and treatment of invasive fungal infection in 47 patients with hematological malignancies].
    Zhu Y; Chen SP; Shu YG; Xu YJ
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):89-92. PubMed ID: 18245913
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Itraconazole versus fluconazole for antifungal prophylaxis.
    Karthaus M; Cornely OA; Ullmann AJ
    Ann Intern Med; 2004 Apr; 140(7):579-80; author reply 581-2. PubMed ID: 15068991
    [No Abstract]   [Full Text] [Related]  

  • 25. [Current Status and Future Perspectives of Primary Antifungal Prophylaxis in Patients with Hematological Malignancies-Review].
    Li Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):627-632. PubMed ID: 28446325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Itraconazole versus fluconazole for antifungal prophylaxis.
    Powers JH; Higgins KM
    Ann Intern Med; 2004 Apr; 140(7):580; author reply 581-2. PubMed ID: 15068992
    [No Abstract]   [Full Text] [Related]  

  • 27. [Prevention and treatment of fungal infections in solid-organ transplant recipients].
    Muñoz P; Bouza E
    Rev Clin Esp; 1995 Oct; 195 Suppl 3():38-48. PubMed ID: 9441304
    [No Abstract]   [Full Text] [Related]  

  • 28. Itraconazole versus fluconazole for antifungal prophylaxis.
    Mossad SB
    Ann Intern Med; 2004 Apr; 140(7):580-1; author reply 581-2. PubMed ID: 15068993
    [No Abstract]   [Full Text] [Related]  

  • 29. A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.
    Oren I; Rowe JM; Sprecher H; Tamir A; Benyamini N; Akria L; Gorelik A; Dally N; Zuckerman T; Haddad N; Fineman R; Dann EJ
    Bone Marrow Transplant; 2006 Jul; 38(2):127-34. PubMed ID: 16751782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylaxis with itraconazole is more effective than prophylaxis with fluconazole in neutropenic patients with hematological malignancies: a meta-analysis of randomized-controlled trials.
    Wang J; Zhan P; Zhou R; Xu J; Shao X; Yang Y; Ouyang J
    Med Oncol; 2010 Dec; 27(4):1082-8. PubMed ID: 19876778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Importance of antifungal prophylaxis in patients who received a nonmyeloablative allogeneic PBSC transplant.
    Mossad SB; Avery RK; Bolwell BJ
    Clin Infect Dis; 2003 Jun; 36(11):1503-4; author reply 1504. PubMed ID: 12766853
    [No Abstract]   [Full Text] [Related]  

  • 32. Misleading statements in industry-sponsored meta-analysis of itraconazole.
    Gøtzsche PC; Johansen HK
    J Clin Oncol; 2005 Dec; 23(36):9428-9; author reply 9429-32. PubMed ID: 16361645
    [No Abstract]   [Full Text] [Related]  

  • 33. How to improve the design of trials of antifungal prophylaxis among neutropenic adults with acute leukemia.
    Menichetti F
    Clin Infect Dis; 2004 Oct; 39 Suppl 4():S181-4. PubMed ID: 15546115
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness analysis of micafungin versus fluconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplantation in Korea.
    Sohn HS; Lee TJ; Kim J; Kim D
    Clin Ther; 2009 May; 31(5):1105-15; discussion 1066-8. PubMed ID: 19539111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fungal prophylaxis in very low birth weight neonates: nystatin, fluconazole or nothing?
    Isaacs D
    Curr Opin Infect Dis; 2008 Jun; 21(3):246-50. PubMed ID: 18448968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Editorial response: A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis.
    Larsen RA
    Clin Infect Dis; 1999 Feb; 28(2):297-8. PubMed ID: 10064247
    [No Abstract]   [Full Text] [Related]  

  • 37. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
    Maertens J
    Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of azoles in antifungal therapy.
    Kauffman CA
    Clin Infect Dis; 1996 May; 22 Suppl 2():S148-53. PubMed ID: 8722843
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Itraconazole for prophylaxis of systemic mycoses in neutropenic patients with haematological malignancies.
    Böhme A; Just-Nübling G; Bergmann L; Shah PM; Stille W; Hoelzer D
    J Antimicrob Chemother; 1996 Dec; 38(6):953-61. PubMed ID: 9023642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Newer antifungal agents for invasive fungal infections in patients with haematological malignancy.
    Rogers TR; Frost S
    Br J Haematol; 2009 Mar; 144(5):629-41. PubMed ID: 19120371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.